Yüklüyor......
The role of vasodilators in the prevention and treatment of no‐reflow following percutaneous coronary intervention
The routine use of vasodilators in patients with acute coronary syndromes or other groups undergoing percutaneous coronary intervention (PCI) cannot be recommended at present. However, in the event of no‐reflow occurring following PCI, intracoronary adenosine or verapamil should be administered
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Group
2006
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1861163/ https://ncbi.nlm.nih.gov/pubmed/16606861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.088427 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|